To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC23931 | Hydrastine |
An alkaloid of Hydrastis canadensis used in many dietary supplements intended to enhance the immune system.
More description
|
|
| DC24153 | Cysteamine hydrochloride |
An agent for the treatment of nephropathic cystinosis and an antioxidant.
More description
|
|
| DC22762 | Norendoxifen |
An active metabolite of the selective estrogen receptor modulator (SERM) tamoxifen.
More description
|
|
| DC23109 | AMZ30 |
AMZ30 is a potent, selective, covalent inhibitor of the serine hydrolase protein phosphatase methylesterase-1 (PME-1) with IC50 of 0.6 uM, >100-fold selectivity over other SHs.
More description
|
|
| DC21996 | AMXT-1501 tetrahydrochloride |
AMXT-1501 tetrahydrochloride (AMXT 1501, AMXT1501) is a novel potent polyamine transport inhibitor, synergistically reduces cell viability in NB cells in combination with DFMO.
More description
|
|
| DC7510 | TAC-101 |
amsilarotene (TAC-101) is a retinobenzoic acid with potential antineoplastic activity. TAC-101 inhibits retinoblastoma-gene product (RB) phosphorylation and increases the presence of 2 cyclin-dependent kinase (CDK) inhibitors, resulting in cell cycle arrest. This agent also causes a cytotoxic decline in cyclin A and thymidylate synthase expression. Check For active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).For the detailed information of TAC-101, the solubility of TAC-101 in water, the solubility of TAC-101 in DMSO, the solubility of TAC-101 in PBS buffer, the animal experiment (test) of TAC-101, the cell expriment (test) of TAC-101, the in vivo, in vitro and clinical trial test of TAC-101, the EC50, IC50,and Affinity of TAC-101, Please contact DC Chemicals..
More description
|
|
| DC9634 | Amsacrine |
Amsacrine (mAMSA) an antineoplastic agent which can intercalate into the DNA of tumor cells.
More description
|
|
| DC7002 | Amrubicin(SM-5887) |
Amrubicin(SM-5887) is a novel anthracycline derivative for treatment of bladder carcinoma.
More description
|
|
| DC23625 | AMR-2 |
AMR-2 is a highly potent, orally active, triple reuptake inhibitor of SERT, NET, and DAT with IC50 of 3.0, 3.1, and 8.3 nM, respectively.
More description
|
|
| DC11076 | Ampreloxetine |
Ampreloxetine (TD-9855) is a potent monoamine reuptake inhibitor with pIC50 of 8.0, 8.6 and 6.8 for human NET, SERT, and DAT, respectively.
More description
|
|
| DC23111 | Ampkinone |
Ampkinone is a novel small molecule activator of AMPK, stimulates the phosphorylation of AMPK via indirect activation of AMPK in various cell lines (2.7-fold at 10 uM).
More description
|
|
| DC11130 | AMPK activator 991 |
AMPK activator 991 is an allosteric AMPK activator, activates non-phosphorylated Thr172 AMPK in vitro binds to α1β1γ1 and α2β1γ1 with Kd of 0.13 and 0.17 uM, respectively..
More description
|
|
| DC9406 | Ampiroxicam |
Ampiroxicam(CP65703) is a nonselective cyclooxygenase inhibitor uesd as anti-inflammatory drug.
More description
|
|
| DC8923 | AS-1413(Amonafide) |
Amonafide(AS1413) produces protein-associated DNA-strand breaks through a topoisomerase II-mediated reaction, but does not produce topoisomerase I-mediated DNA cleavage.
More description
|
|
| DC20188 | Amodiaquine |
Amodiaquine is a synthetic aminoquinoline that acts by binding to the protozoal or parasitic DNA and preventing DNA and RNA production and subsequent protein synthesis. It is used for the therapy of malaria.
More description
|
|
| DC20206 | Amitriptyline;MK-230, N-750, Ro41575 |
Amitriptyline is a tricyclic antidepressant (TCA) with analgesic properties, widely used to treat depression and neuropathic pain.
More description
|
|
| DC11193 | Aminopyridine 2 |
Aminopyridine 2 (MPO inhibitor AP-2) is a novel potent, selective, orally available inhibitor of Myeloperoxidase (MPO), inhibits MPO peroxidase activity in vitro and in human plasma with IC50 of 0.16 and 1.9 uM, respectively.
More description
|
|
| DC11324 | Aminopeptidase N Inhibitor |
Aminopeptidase N (AP-N) inhibitor is a reversible inhibitor of AP-N/CD13 (IC50 = 25 μM).
More description
|
|
| DC9548 | Amicarbazone |
Amicarbazone(BAY-MKH3586; BAY314666) is a potent inhibitor of photosynthetic electron transport via binding to the Qb domain of photosystem II (PSII); herbicide with a broad spectrum of weed control.
More description
|
|
| DC11180 | Amgen 16 |
Amgen16 is a highly potent inhibitor of NF-κB inducing Kinase (NIK), example 294 in patent WO 2009158011 A1..
More description
|
|
| DC12430 | AMG7703 |
AMG7703 (4-CMTB, AMG-7703) is an allosteric, selective agonist of FFAR2 (GPR43)..
More description
|
|
| DC11878 | AMG-579 |
AMG-579 is a potent, selective, CNS penetrant, orally bioavailable PDE10A inhibitor with IC50 of 0.1 nM.
More description
|
|
| DC23850 | AMG-458(AMG458;AMG 458) |
AMG-458 (AMG458) is a potent, selective, orally bioavailable c-Met inhibitor with Ki of 1.2 nM (human c-Met).
More description
|
|
| DC9793 | AMG232 |
AMG232 is a potent, selective and orally bioavailable inhibitor of MDM2−p53 interaction with IC50 value of 9.1 nM in EdU cells .
More description
|
|
| DC20661 | AMG-1694 |
AMG1694 is a potent, small molecule Glucokinase (GK)-GKRP (GK regulatory protein) disruptor, does not block the GK binding site directly.
More description
|
|
| DC20660 | AMG-076 |
AMG-076 is a potent, selective, non-peptide antagonist of MCHR1 (Melanin-concentrating hormone receptor 1) with binding IC50 of 0.6 nM, with dramatically reduced hERG liability (IC50>5 uM).
More description
|
|
| DC6310 | AMG 853(AMG853;Vidupiprant) |
AMG 853 is novel a CRTH2 and DP Dual Antagonist.
More description
|
|
| DC9457 | AMG 837 (calcium hydrate) |
AMG 837 calcium hydrate is a potent GPR40 agonist(EC50=13 nM) with a superior pharmacokinetic profile and robust glucose-dependent stimulation of insulin secretion in rodents.
More description
|
|
| DC12002 | AMG 580 |
AMG 580 (AMG580) is a novel potent, selective phosphodiesterase 10A (PDE10A) inhibitor with IC50 of 0.13 nM.
More description
|
|
| DC20792 | Amelubant |
Amelubant (BIIL284) is a potent, long-acting, orally active leukotriene B4 (LTB4) receptor antagonist, inhibits LTB4-induced mouse ear inflammation with ED50 of 0.008 mg/kg (p.o.).
More description
|
|